10,000 Shares in Astera Labs, Inc. $ALAB Purchased by Twin Peaks Capital Ltd

Twin Peaks Capital Ltd bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 10,000 shares of the company’s stock, valued at approximately $4,830,000. Astera Labs comprises approximately 2.4% of Twin Peaks Capital Ltd’s portfolio, making the stock its 10th biggest holding.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Reflection Asset Management purchased a new position in shares of Astera Labs during the fourth quarter worth approximately $25,000. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the 2nd quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Astera Labs during the 2nd quarter valued at $30,000. Whipplewood Advisors LLC grew its holdings in shares of Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the 2nd quarter worth $35,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB traded up $15.22 during midday trading on Wednesday, reaching $267.76. 1,635,366 shares of the stock traded hands, compared to its average volume of 5,248,213. The company has a fifty day moving average of $310.48 and a 200 day moving average of $262.88. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock has a market capitalization of $46.45 billion, a P/E ratio of 132.56 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm earned $0.44 EPS. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the subject of several recent research reports. Jefferies Financial Group boosted their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. TD Cowen lowered their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada increased their target price on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $348.33.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 592,244 shares of company stock valued at $209,729,973 in the last quarter. 10.40% of the stock is currently owned by company insiders.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.